EXHIBIT
99.03





Sangui
BioTech International , Inc.


1393
North Bennett Circle


Farmington,
Utah 84025




c/o
Sangui BioTech Gmbh


Alfred-Herrhausen-Str.
44


58455
Witten


SanguiBioTech
presented wound management products at leading Jordan medical
institutions
  Witten,
Germany, October 29, 2008 - Management and medical staff of SanguiBioTech GmbH
held a series of presentations at leading medical institutions in the Kingdom of
Jordan in the week of October 20, 2008. Visited were, among others, the central
military hospital of the Royal Medicine Services, the headquarters of Jordan
Civil Defence, which also directs Jordan's entire emergency rescue system, the
King Abdullah University Hospital in Irbid
(http://www.kauh.jo/kauh/english/index.aspx), as well as Jordan's largest health
center, the Al Basheer Hospital in Amman.
  Along
with top representatives of the respective hospital managements high ranking
surgeons and rescue doctors as well as directors of cardiological,
dermatological, oncological and orthopedical departments participated in the
meetings which were attended by about 20 to 30 persons each. Introduced were the
Chitosan based wound dressings, i.e. the already registered CHITOSKIN dressings
as well as the newly developed dressing for surgical applications. Moreover, the
presentations extended to the wound healing system for chronic wounds including
SCABREMOVE and HEMO2SPRAY. Products and concepts met thorough interest and were
intensely discussed among the experts.
  The
series of presentations had been organized by Abu-Jabir Industrial and Marketing
Consulting (www.abu-jabir.com). Besides its headquarters in Amman, Jordan,
Abu-Jabir operates subsidiaries in the United Arab Emirates and in Egypt. Sharif
Abu-Jabir, founder and president of this enterprise, emphasized: "Since the
inception of our close cooperation with Sangui in spring 2007 we have
established the basis for widespread business activities in the Arab countries.
The current status lets us expect a sound and sustainable demand for Sangui
products after having them registered." The distribution partner in Jordan will
be the pharmaceuticals trading house Nobles Medical Supplies Company
Ltd.
  Sangui
Managing Director Hubertus Schmelz was impressed by the success of the
presentations: "We have had the opportunity to visit large, top modern and
excellently equipped hospitals, which influence the wound care system of the
entire Kingdom. The positive reactions of the medical experts as well as the
highly professional support provided by Abu-Jabir and by its distribution
partners give rise to considerable expectations for our future cooperation." It
was too early, however, Schmelz added, to prepare a reliable time frame and
business plan.


SanguiBioTech
GmbH is a subsidiary of Sangui Biotech International, Inc.


(www.pinksheets.com:
SGBI)




For more
information please contact:




Joachim
Fleing


Phone:
+49 (160) 741 27 17


Fax: +49
(2302) 915 191


e-mail:
fleing@sangui.de




Forward
Looking Statements




Some of
the statements contained in this news release discuss future expectations,
contain projections of results of operation or financial condition or state
other “forward-looking” information. These statements are subject to known and
unknown risks, uncertainties, and other factors that could cause the actual
results to differ materially from those contemplated by the statements. The
forward-looking information is based on various factors and is derived using
numerous assumptions. Important factors that may cause actual results to differ
from projections include, among many others, the ability of the Company to raise
sufficient capital to meet operating requirements. Words such as “anticipates,”
“expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and variations
of such words and similar expressions are intended to identify such
forward-looking statements. Unless required by law, the Company undertakes no
obligation to update publicly any forward-looking statements, whether as a
result of new information, future events or
otherwise.